Human medicines European public assessment report (EPAR): Ogivri, trastuzumab, Date of authorisation: 12/12/2018, Revision: 12, Status: Authorised

Submitted by Anonymous (not verified) on 14 November 2024 - 9:59

Human medicines European public assessment report (EPAR): Ogivri, trastuzumab, Date of authorisation: 12/12/2018, Revision: 12, Status: Authorised

Q&A clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - 22 October 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 October 2024, 10:00 (CEST) to 22 October 2024

Submitted by Anonymous (not verified) on 13 November 2024 - 15:46

Q&A clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - 22 October 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 October 2024, 10:00 (CEST) to 22 October 2024, 10:30 (CEST)

Biannual Big Data Steering Group and industry stakeholders meeting - Oct 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 25 October 2024, 09:00 (CEST) to 25 October 2024, 11:00 (CEST)

Submitted by Anonymous (not verified) on 13 November 2024 - 15:34

Biannual Big Data Steering Group and industry stakeholders meeting - Oct 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 25 October 2024, 09:00 (CEST) to 25 October 2024, 11:00 (CEST)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More